SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

KIMS (KIMS) News

Follow KIMS (KIMS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol KIMS Asset market Sector Markets 90 days 5 Updated Oct 06, 2026, 02:28 PM UTC Open live news feed
M KIMS Q2 Net Profit Rises 11.9% to ₹75 Crore as Revenue Jumps 39.9% Krishna Institute of Medical Sciences reported consolidated Q2 net profit of ₹75 crore, up from ₹67 crore a year earlier. Revenue from operations increased to ₹1,344 crore from ₹961 crore, while margins declined. EQUITY | Nov 04, 2026, 03:26 PM UTC M Krishna Institute Of Medical Sciences To Acquire Up To 51% Stake In Insignia Healthcare Krishna Institute of Medical Sciences Ltd announced plans to acquire up to a 51% equity stake in Insignia Healthcare. EQUITY | Oct 06, 2026, 02:28 PM UTC L Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 6% on Wednesday Shares of Hospital Stocks Apollo Hospitals Ltd.,Fortis Healthcare Ltd., Max Healthcare Ltd., Krishna Institute of Medical Sciences Ltd., Narayana Health Ltd.,Global Health Ltd. among others are all trading with losses be EQUITY | Sep 30, 2026, 06:28 AM UTC L KIMS Enters Exclusive Operations And Management Agreement With Sarvottam Health Care Krishna Institute of Medical Sciences Ltd NSE:KIMS EQUITY | Sep 10, 2026, 02:45 PM UTC L KIMS enters O&M agreement to manage 183-bed Trust Hospital in Kakinada Krishna Institute of Medical Sciences Ltd (KIMS) said it entered an Operations and Management (O&M) Agreement with Sarvottam Health Care Private Ltd (SHPL). The deal gives SHPL exclusive terms to manage, operate, direct EQUITY | Sep 10, 2026, 01:33 PM UTC L Investec initiates coverage on KIMS with ₹1,000 buy target Krishna Institute of Medical Sciences (KIMS) gained after Investec initiated coverage with a “buy” rating and a target price of ₹1,000 per share. EQUITY | Sep 03, 2026, 07:56 AM UTC